BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31521848)

  • 1. Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center.
    Udyaver S; Dalvin LA; Lim LS; Mazloumi M; Atalay HT; Khoo CTL; Shields JA; Shields CL
    J AAPOS; 2019 Oct; 23(5):266.e1-266.e9. PubMed ID: 31521848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center.
    Khoo CTL; Dalvin LA; Lim LS; Mazloumi M; Atalay HT; Udyaver S; Shields JA; Shields CL
    Asia Pac J Ophthalmol (Phila); 2019; 8(4):290-297. PubMed ID: 31356365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification and management of Coats disease: the 2000 Proctor Lecture.
    Shields JA; Shields CL; Honavar SG; Demirci H; Cater J
    Am J Ophthalmol; 2001 May; 131(5):572-83. PubMed ID: 11336931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
    Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
    JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.
    Shields JA; Shields CL; Honavar SG; Demirci H
    Am J Ophthalmol; 2001 May; 131(5):561-71. PubMed ID: 11336930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
    Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
    Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF COATS DISEASE IN A SAUDI ARABIAN POPULATION.
    Al-Qahtani AA; Almasaud JM; Ghazi NG
    Retina; 2015 Oct; 35(10):2091-9. PubMed ID: 25978728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of Total Exudative Retinal Detachments in Stage 3B Coats Disease.
    Li AS; Capone A; Trese MT; Sears JE; Kychenthal A; De la Huerta I; Ferrone PJ
    Ophthalmology; 2018 Jun; 125(6):887-893. PubMed ID: 29361355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.
    Krivosic V; Massin P; Desjardins L; Le Hoang P; Tadayoni R; Gaudric A
    Am J Ophthalmol; 2014 Jul; 158(1):154-161.e1. PubMed ID: 24631475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of retinal detachment in Coats disease. Study of 15 cases.
    Mrejen S; Metge F; Denion E; Dureau P; Edelson C; Caputo G
    Retina; 2008 Mar; 28(3 Suppl):S26-32. PubMed ID: 18317340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
    Bopp S; Lucke K; Laqua H
    Ger J Ophthalmol; 1992; 1(6):375-81. PubMed ID: 1283355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of moderate to advanced Coats' disease.
    Kiratli H; Eldem B
    Ophthalmologica; 1998; 212(1):19-22. PubMed ID: 9438579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coats' disease of adult-onset in 48 eyes.
    Rishi E; Rishi P; Appukuttan B; Uparkar M; Sharma T; Gopal L
    Indian J Ophthalmol; 2016 Jul; 64(7):518-23. PubMed ID: 27609165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery.
    Barile GR; Chang S; Horowitz JD; Reppucci VS; Schiff WM; Wong DT
    Am J Ophthalmol; 1998 Sep; 126(3):379-89. PubMed ID: 9744371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifting the White Walker's curse-Management of Coats' disease.
    Kelkar A; Bolisetty M
    Indian J Ophthalmol; 2023 Aug; 71(8):3117. PubMed ID: 37530299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children.
    Al Freihi SH; Edward DP; Nowilaty SR; Abouammoh MA; Morales J
    J Glaucoma; 2013; 22(4):336-41. PubMed ID: 22138687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coats disease in a 3-week-old boy.
    Lim Fat CP; Lee SY; Brundler MA; Scott CM; Parulekar MV
    J AAPOS; 2014 Feb; 18(1):86-8. PubMed ID: 24568994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases.
    Dalvin LA; Udyaver S; Lim LS; Mazloumi M; Atalay HT; Khoo CTL; Shields CL
    J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):288-296. PubMed ID: 31545862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.